Literature DB >> 10585987

Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association.

D D Marshall1, M Kotelchuck, T E Young, C L Bose, L Kruyer, T M O'Shea.   

Abstract

OBJECTIVE: To identify risk factors for chronic lung disease (CLD) in a population-based cohort of very low birth weight infants, born in an era of surfactant usage. We specifically investigated the effects of antenatal steroids, nosocomial infection, patent ductus arteriosus (PDA), fluid management, and ventilator support strategies.
METHODS: Data were prospectively collected on 1244 infants born in North Carolina in 1994 with birth weights 500 to 1500 g, and treated at 1 of the 13 intensive care nurseries across the state. The outcome of interest was CLD, defined as dependency on supplemental oxygen at 36 weeks' postmenstrual age. Multivariate odds ratios (OR) and 95% confidence intervals (CI) were estimated with logistic regression models.
RESULTS: Among 865 survivors to 36 weeks' postmenstrual age, 224 (26%) had CLD. Nosocomial infection (OR: 2.0; 95% CI: 1.4-3.3), fluid intake on day 2 (OR: 1.06 per 10 mL increase; 95% CI: 1.01-1.11), and the need for ventilation at 48 hours of life (OR: 2.2; 95% CI: 1.3-3.7) were associated with an increased risk of CLD. Among infants ventilated at 48 hours, nosocomial infection (OR: 1.64; 95% CI: 1.02-2.62) and PDA (OR: 1.9; 95% CI: 1.2-3.1) were associated with an increased risk. No association was found with antenatal steroid receipt or increased levels of ventilator support.
CONCLUSION: This analysis suggests that with widespread use of surfactant, nosocomial infection, PDA, and water balance persist as risk factors for CLD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10585987     DOI: 10.1542/peds.104.6.1345

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  56 in total

1.  Improved closure of patent ductus arteriosus with high doses of ibuprofen.

Authors:  Udo Meißner; Raktima Chakrabarty; Hans-Georg Topf; Wolfgang Rascher; Michael Schroth
Journal:  Pediatr Cardiol       Date:  2012-02-04       Impact factor: 1.655

2.  Surfactant use based on the oxygenation response to lung recruitment during HFOV in VLBW infants.

Authors:  Pierre Tissières; Patrick Myers; Maurice Beghetti; Michel Berner; Peter C Rimensberger
Journal:  Intensive Care Med       Date:  2010-03-16       Impact factor: 17.440

3.  A trial of recombinant human granulocyte colony stimulating factor for the treatment of very low birthweight infants with presumed sepsis and neutropenia.

Authors:  A R Bedford Russell; A J Emmerson; N Wilkinson; T Chant; D G Sweet; H L Halliday; B Holland; E G Davies
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-05       Impact factor: 5.747

Review 4.  Patent ductus arteriosus: lack of evidence for common treatments.

Authors:  Carl L Bose; Matthew M Laughon
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-11       Impact factor: 5.747

5.  Surfactant reduced the mortality of neonates with birth weight ⩾1500 g and hypoxemic respiratory failure: a survey from an emerging NICU network.

Authors:  H Wang; X Gao; C Liu; C Yan; X Lin; Y Dong; B Sun
Journal:  J Perinatol       Date:  2017-02-02       Impact factor: 2.521

Review 6.  The role of fluid overload in the prediction of outcome in acute kidney injury.

Authors:  David T Selewski; Stuart L Goldstein
Journal:  Pediatr Nephrol       Date:  2016-11-30       Impact factor: 3.714

7.  Trends in Patent Ductus Arteriosus Diagnosis and Management for Very Low Birth Weight Infants.

Authors:  Samantha Ngo; Jochen Profit; Jeffrey B Gould; Henry C Lee
Journal:  Pediatrics       Date:  2017-04       Impact factor: 7.124

8.  Fluid overload and mortality are associated with acute kidney injury in sick near-term/term neonate.

Authors:  David J Askenazi; Rajesh Koralkar; Hayden E Hundley; Angela Montesanti; Neha Patil; Namasivayam Ambalavanan
Journal:  Pediatr Nephrol       Date:  2012-12-09       Impact factor: 3.714

9.  Association between prophylactic indomethacin and death or bronchopulmonary dysplasia: A systematic review and meta-analysis of observational studies.

Authors:  Erik A Jensen; Elizabeth E Foglia; Barbara Schmidt
Journal:  Semin Perinatol       Date:  2018-05-10       Impact factor: 3.300

10.  Urinary NT-proBNP levels and echocardiographic parameters for patent ductus arteriosus.

Authors:  S S Khan; T Sithisarn; H S Bada; M Vranicar; P M Westgate; M Hanna
Journal:  J Perinatol       Date:  2017-09-14       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.